FindTrial
Sign In

Histamiini H2 salpaus liitännäishoitona puutteellisen hoitovasteen skitsofreniassa

Histamiini H2 salpaus liitännäishoitona puutteellisen hoitovasteen skitsofreniassa

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-006636-22-FI
Enrollment
Unknown
Registered
2007-01-22
Start date
2007-04-05
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skitsofreniapotilaat joiden hoitovaste on puutteellinen. MedDRA version: 9.1 Level: LLT Classification code 10039626 Term: Schizophrenia

Interventions

Trade Name: Pepcidin Pharmaceutical Form: INN or Proposed INN: FAMOTIDINE CAS Number: 76824356 INN or Proposed INN: FAMOTIDINE CAS Number: 76824356 Pharmaceutical form of the placebo: Capsule* Route

Sponsors

Jesper Ekelund
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026